Fig. 1
From: Altered expression profile of BAFF receptors on peripheral blood B lymphocytes in Graves’ disease
Increased serum BAFF levels in AITD patients. Serum BAFF levels were elevated in GD patients (1.183 ± 0.334 ng/ml) and HT patients (1.02 ± 0.24), comparing with healthy controls (0.934 ± 0.238 ng/ml). AITD: autoimmune thyroid disease; HC: healthy controls; GD: Graves’ disease; HT: Hashimoto’s thyroiditis; Bars: mean BAFF levels; ns: not significant; *: vs. HC, P < 0.05, **: vs. HC, P < 0.01